68ga-nota-aca-bbn

Small moleculeexperimentalImaging agent

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2015 (NCT02520882)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetRadiopharmaceutical

    radiopharmaceutical

Chemistry & pharmacology

Imaging
68-gallium

Oral

No

Parenteral

No

Topical

No

Also known as

  • 68ga-nota-aca-bbn

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02520882Early Phase 1 (Phase 1)Jan 1, 2015National Institutes of Health (NIH), Tsinghua University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institutes of Health (NIH)Government1012015
Tsinghua UniversityAcademic/Hospital1112015
2 organizations
Page 1 / 1